查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010025

医疗图像市场：2026-2032年全球市场预测（依影像方式、组件、应用、最终用户、解剖部位和部署方式划分）

Medical Imaging Market by Modality, Component, Application, End User, Anatomy, Deployment Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗图像市场价值将达到 704.6 亿美元，到 2026 年将成长至 796.3 亿美元，到 2032 年将达到 1880.7 亿美元，复合年增长率为 15.05%。

主要市场统计数据
基准年 2025 704.6亿美元
预计年份：2026年 796.3亿美元
预测年份 2032 1880.7亿美元
复合年增长率 (%) 15.05%

一个简洁的框架，用于描述不断发展的医疗图像生态系统，将模式创新、临床需求和营运要求与策略决策连结起来。

医疗图像领域正处于快速技术创新、不断演进的临床路径以及所有医疗机构日益增长的营运压力交汇点。影像撷取、处理演算法和资讯学的进步拓展了诊断能力，同时也提高了人们对互通性、资料安全性和工作流程效率的期望。同时，医疗系统也在努力改善治疗效果并控製成本，这使得对既能展现临床价值又能无缝整合到更广泛的数位健康生态系统中的影像解决方案的需求日益增长。

模式进步、人工智慧软体、整合服务和混合分销模式如何重新定义竞争优势和临床应用动态。

一场重大变革正在重塑诊断影像技术的开发、实施和使用方式，这要求製造商、医疗服务提供者和保险公司都积极做出调整。人工智慧 (AI) 和先进的影像分析技术正在加速诊断处理能力并增强临床解读，从而改变了人们对软体和资料管理的期望，无论这些软体和资料是部署在本地还是云端部署。同时，从电脑断层扫描 (CT) 的进步（例如锥状射束CT、PET-CT 混合成像和频谱成像），到磁振造影(MRI) 和不断扩展的光学成像方式，硬体的进步正在持续推动解析度和功能洞察力的提升。

本研究评估了新的关税政策如何使供应链复杂化，促使製造地向区域内转移，并改变耐用医疗影像技术的采购重点。

2025年关税和贸易措施的实施将对整个医疗图像供应链产生影响，波及采购选择、采购週期以及与供应商的关係。先前依赖跨境进口零件和成品的供应商正面临投入成本上升和前置作业时间延长的困境，促使客户和製造商重新评估筹资策略。为此，一些製造商正在加快区域製造和组装以降低关税风险，而另一些製造商则在与供应商重新谈判合约或探索替代物流路线，以维持交货时间和利润结构。

从细分市场的观点揭示了模式功能、软体和服务生态系统以及部署偏好如何相互作用并决定临床和商业性成功。

分析细分市场层面的趋势揭示了不同模式、组件、应用、终端用户、解剖靶区、交付模式和分销管道所面临的差异化机会和营运挑战。电脑断层扫描（CT），包括锥状射束CT、PET-CT和频谱CT等变体，因其高速和多能量成像能力可提高诊断清晰度，持续吸引投资；而磁振造影（MRI）系统则在软组织对比度和先进序列技术有助于治疗计划的领域推动着需求。核子医学影像在分子诊断中发挥着至关重要的作用，尤其是在肿瘤学和神经病学领域，正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT）的应用尤为突出。同时，光学成像和超音波正在拓展其诊断应用，包括术中引导和床边评估。 X光系统在急诊医学和常规临床实践中仍然至关重要，数位化的应用提高了工作流程和影像品质。

基础设施、还款方案、监管方法和製造能力的区域趋势决定了采用途径和打入市场策略的差异。

区域趋势凸显了基础设施成熟度、报销环境、法律规范和製造地如何影响技术应用轨迹和策略重点。在美洲，资本投资能力、先进的医院网路和完善的监管管道正在推动高端技术和分析主导解决方案的快速普及，同时也为健全的售后服务模式提供了支援。过渡性资金筹措机制和私营部门的创新正在促进伙伴关係的建立，从而加速新兴影像技术的临床应用。

主要企业如何透过收购、人工智慧伙伴关係、本地化服务和灵活分销来建立强大的产品组合併扩大其在临床领域的覆盖范围？

医疗图像领域的竞争格局是由产品创新、策略伙伴关係、售后服务以及对软体和数据能力的定向投资共同塑造的。主要企业正透过收购、与人工智慧专家合作以及与临床研究中心合作来拓展产品组合，以加速新应用的检验和监管核准。这些措施旨在建构一个整合的生态系统，将成像硬体、分析主导软体和全面的服务产品结合，从而降低应用门槛并提升产品生命週期价值。

一套实用且多方面的策略手册，将产品模组化、软体和服务、供应链弹性以及区域上市时间策略相结合，以确保可持续的竞争优势。

产业领导企业必须采取切实可行的多方位策略方案，以最大限度地掌握机会，同时降低营运和政策风险。首先，优先考虑模组化和在地化设计，以降低关税成本波动的影响，并实现在地化的快速组装和配置。其次，增加对提升硬体价值的软体和服务的投资，特别是人工智慧驱动的分析、云端或混合数据管理以及临床医生培训，以创造持续的收入来源并提高客户维繫。第三，透过多元化采购、关键零件的策略性库存缓衝以及应对贸易突发事件的合约保障措施，提高供应链透明度。

透过采用以证据为基础的调查方法，结合专家访谈、系统性文献分析、情境评估和交叉检验，我们获得了严谨而实用的见解。

本研究途径整合了第一手和第二手调查，建构了可靠的证据基础，并透过相关人员三​​角检验检验了主题研究结果。第一手调查包括对临床负责人、采购专家、放射科医生以及製造商和分销商高管进行结构化访谈，并进行专家访谈，以直接了解营运挑战、应用驱动因素和服务期望。第二手调查包括对同行评审文献、监管指南、专利申请、公司资讯披露和技术白皮书进行系统性回顾，以阐明技术趋势和历史发展。

一份简洁、全面的分析报告，将技术进步、服务主导的差异化和价值链韧性连结起来，作为永续采用和价值交付的核心决定因素。

总而言之，在硬体、分析技术和服务交付模式的进步融合以及政策和采购趋势转变的共同推动下，医疗图像领域正经历持续的变革。儘管特定成像方式的创新不断拓展诊断和治疗能力，但决定性的差异化因素正日益转向软体整合、售后服务和供应链的适应性。贸易政策趋势凸显了在地化、模组化设计和采购多元化的重要性，促使相关人员重新评估其采购框架，并在整个生命週期中优先考虑价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗图像市场：依影像方式划分

  • 电脑断层扫描
    • 锥状射束CT
    • PET-CT
    • 频谱CT
  • 磁振造影
  • 核子医学扫描术诊断
    • 正子断层扫描
    • 单光子发射电脑断层扫描
  • 光学成像
  • 超音波
  • X射线

第九章：医疗图像市场：依组件划分

  • 硬体
  • 服务
    • 安装与集成
    • 维护和支援
    • 培训和教育
  • 软体

第十章：医疗图像市场：依应用领域划分

  • 循环系统
  • 胃肠病学
  • 神经病学
  • 妇产科
  • 肿瘤学
  • 整形外科
  • 泌尿系统

第十一章：医疗图像市场：依最终使用者划分

  • 门诊手术中心
  • 诊所
  • 诊断影像中心
  • 医院

第十二章 按解剖部位分類的医疗图像市场

  • 腹部
  • 脑
  • 胸部
  • 心血管系统
  • 肌肉骨骼系统
  • 儿童
  • 脊椎

第十三章：医疗图像市场：依部署模式划分

  • 云
  • 现场

第十四章：医疗图像市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：医疗图像市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章医疗图像市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医疗图像市场

第十八章：中国医疗图像市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Carl Zeiss Meditec AG
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Planmeca Oy
  • RadNet, Inc.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Varex Imaging Corporation
Product Code: MRR-434CCDA04E90

The Medical Imaging Market was valued at USD 70.46 billion in 2025 and is projected to grow to USD 79.63 billion in 2026, with a CAGR of 15.05%, reaching USD 188.07 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 70.46 billion
Estimated Year [2026] USD 79.63 billion
Forecast Year [2032] USD 188.07 billion
CAGR (%) 15.05%

A concise framing of the evolving medical imaging ecosystem that links modality innovation, clinical demand, and operational imperatives to strategic decision-making

The medical imaging landscape sits at the intersection of rapid technological innovation, evolving clinical pathways, and intensifying operational pressures across care settings. Advances in image acquisition, processing algorithms, and informatics have expanded diagnostic capabilities while simultaneously raising expectations for interoperability, data security, and workflow efficiency. Meanwhile, health systems pursue improved outcomes and cost management, which amplifies demand for imaging solutions that demonstrate clinical value and seamless integration into broader digital health ecosystems.

Against this backdrop, stakeholders from manufacturers to hospital procurement teams are reassessing investment priorities. Vendors are moving beyond single-product strategies toward software-enabled platforms and service-centric models that support lifecycle value and recurring revenue. Clinicians increasingly rely on multimodal imaging to guide diagnosis and therapy, which elevates the importance of modality-specific strengths and integration across modalities. Consequently, decision-makers must consider not only technology performance but also supply chain resilience, regulatory compliance, and the workforce implications of adopting advanced imaging tools.

In the following sections, the report synthesizes how modality innovation, component ecosystems, application-specific requirements, end-user dynamics, anatomical focus areas, deployment preferences, and distribution approaches collectively shape strategic opportunities and operational risks for organizations across the medical imaging value chain.

How modality advancements, AI-enabled software, integrated services, and hybrid distribution models are collectively redefining competitive advantage and clinical adoption dynamics

Major disruptive forces are reshaping how imaging technologies are developed, deployed, and consumed, and these shifts demand proactive adaptation from manufacturers, providers, and payers alike. Artificial intelligence and advanced image analytics are accelerating diagnostic throughput and augmenting clinical interpretation, which in turn changes expectations for software and data management across on-premise and cloud deployment modes. At the same time, hardware evolution-spanning computed tomography with advances such as cone beam CT, PET-CT hybrids and spectral imaging, to magnetic resonance and expanding optical imaging modalities-continues to enhance resolution and functional insights.

Simultaneously, nuclear imaging retains importance for metabolic and molecular assessments, with positron emission tomography and single photon emission computed tomography driving specialized clinical protocols. Ultrasound and X-ray remain indispensable for point-of-care and routine diagnostics, prompting manufacturers to invest in portability and user-friendly interfaces. Component ecosystems are shifting toward integrated offerings where hardware, software, and services such as installation, maintenance and targeted training converge to deliver measurable value. Furthermore, distribution strategies that blend direct sales with indirect channels including dealers, distributors and online retailers are optimizing reach and aftermarket support, while end users from hospitals and diagnostic imaging centers to clinics and ambulatory surgical centers demand flexible pricing and deployment options. As a result, organizations must craft strategies that align modality strengths with application areas such as cardiology, oncology and neurology, account for anatomical focus from cardiovascular to pediatric imaging, and balance cloud-enabled analytics with on-premise control to meet clinical, security and operational objectives.

Assessing how new tariff policies introduce supply chain complexity, prompt regional manufacturing shifts, and alter procurement priorities for durable imaging technologies

The introduction of tariffs and trade measures in 2025 has reverberated across the medical imaging supply chain, influencing sourcing choices, procurement cycles, and supplier relationships. Suppliers that previously relied on cross-border components and finished equipment imports have faced increased input costs and longer lead times, prompting both customers and manufacturers to reevaluate their procurement strategies. In response, some manufacturers have accelerated regional manufacturing or assembly to mitigate tariff exposure, while others have renegotiated supplier contracts or pursued alternative logistics pathways to preserve delivery schedules and margin structures.

Consequently, health systems and imaging providers have reassessed capital procurement priorities and service agreements, often emphasizing total cost of ownership and long-term serviceability over short-term price reductions. The tariffs have also intensified discussions around vendor diversification, with procurement teams seeking multi-sourced options to reduce concentration risk. Moreover, regulatory compliance and documentation requirements associated with cross-border trade have added administrative complexity, influencing lead times for installation and integration services. Importantly, these dynamics have strengthened the strategic significance of aftermarket services and localized support, as providers place higher value on reliable maintenance, rapid spare parts availability, and vendor responsiveness to sustain clinical operations.

Looking ahead, the cumulative impact of trade policy is encouraging stakeholders to invest in supply chain transparency, scenario planning, and contractual terms that explicitly address tariff contingencies. In parallel, manufacturers are evaluating product redesign and modularization approaches to localize higher-value components and reduce tariff exposure, thereby preserving competitiveness while maintaining clinical performance and safety standards.

Segment-level perspectives that reveal how modality capabilities, software and service ecosystems, and deployment preferences interact to determine clinical and commercial success

Examining segment-level dynamics reveals differentiated opportunities and operational challenges across modalities, components, applications, end users, anatomical focus areas, deployment modes, and distribution channels. Computed tomography, including cone beam CT, PET-CT and spectral CT variants, continues to attract investment where speed and multi-energy imaging deliver diagnostic clarity, while magnetic resonance systems drive demand where soft tissue contrast and advanced sequences inform therapeutic decision-making. Nuclear imaging maintains a crucial role for molecular diagnostics via positron emission tomography and single photon emission computed tomography, especially in oncology and neurology, whereas optical imaging and ultrasound extend diagnostic reach to intraoperative guidance and point-of-care assessment. X-ray systems remain foundational across emergency and routine care settings, benefitting from digital upgrades that enhance workflow and image quality.

From a component perspective, hardware remains fundamental to imaging performance, but software and services increasingly determine differentiation. Service bundles that include installation and integration, robust maintenance and support, and clinician-focused training and education enable faster clinical adoption and higher uptime. Application-driven requirements steer modality selection: cardiology and oncology demand high-resolution, reproducible protocols and advanced analytics, while obstetrics, orthopedics and pediatrics emphasize patient comfort, dose optimization and tailored workflow solutions. End users such as hospitals and diagnostic imaging centers prioritize scalability, accreditation support and comprehensive service agreements, whereas clinics and ambulatory surgical centers often value compact form factors, cost-effective deployment models and simplified maintenance.

Anatomical focus areas-from cardiovascular and brain imaging to breast and spine diagnostics-shape device specifications, imaging protocols and reporting tools. Deployment mode choices between cloud and on-premise arrangements hinge on data governance, latency requirements and institutional IT strategies, and distribution approaches that combine direct sales with indirect channels like dealers, distributors and online retailers influence market reach and aftermarket responsiveness. Collectively, these segmentation insights underscore that winning strategies integrate modality-specific innovation, software-enabled workflows and service-driven support tailored to the unique needs of clinical applications and care settings.

Regional patterns in infrastructure, reimbursement, regulatory approaches, and manufacturing capacity that determine differentiated adoption pathways and go-to-market strategies

Regional dynamics underscore how infrastructure maturity, reimbursement environments, regulatory frameworks, and manufacturing footprints influence adoption trajectories and strategic priorities. In the Americas, capital investment capacity, advanced hospital networks, and established regulatory pathways have fostered rapid uptake of high-end modalities and analytics-driven solutions, while also supporting robust aftermarket service models. Transitional funding mechanisms and private sector innovation encourage partnerships that accelerate clinical integration of emerging imaging technologies.

Across Europe, the Middle East and Africa, heterogeneous healthcare systems and varied reimbursement approaches create differentiated demand patterns; some markets prioritize cost-effective, portable imaging solutions to extend diagnostic reach, while others emphasize high-acuity modalities paired with sophisticated data management to support complex clinical pathways. Regulatory harmonization efforts and regional collaborations influence cross-border procurement and supply chain planning. Meanwhile, Asia-Pacific exhibits a mix of advanced technology adoption in urban centers and growing demand for scalable, portable, and tele-enabled imaging in underserved areas. Rapidly expanding hospital infrastructure, growing local manufacturing capabilities and strategic government investments in health technology drive dynamic vendor strategies and partnerships across the region.

Taken together, these regional distinctions require vendors and providers to calibrate product portfolios, service offerings, and distribution models to local clinical needs, regulatory requirements and procurement practices, while leveraging regional strengths such as manufacturing hubs, telehealth networks, and public-private partnerships to optimize access and operational resilience.

How leading firms are combining acquisitions, AI partnerships, localized services, and flexible distribution to build resilient portfolios and expand clinical reach

Competitive trajectories within the medical imaging landscape are shaped by a mix of product innovation, strategic partnerships, aftermarket services, and targeted investments in software and data capabilities. Leading firms are broadening portfolios through acquisitions, alliances with AI specialists and collaborations with clinical research centers to validate new applications and accelerate regulatory approvals. These efforts aim to create integrated ecosystems that combine modality hardware, analytics-driven software, and comprehensive service offerings that reduce adoption friction and enhance lifecycle value.

At the same time, an emergent cohort of specialized vendors focuses on niche segments such as portable ultrasound, spectral CT enhancements or cloud-native image management, compelling larger incumbents to adopt flexible partnership models. Aftermarket service differentiation-encompassing rapid installation, preventative maintenance, spare parts logistics and clinician training-has become a competitive lever, particularly when supply chain uncertainties amplify the value of localized support. Moreover, distribution strategies that incorporate both direct engagement with large health systems and indirect channels to extend reach into ambulatory care and clinics allow companies to optimize coverage and responsiveness. As stakeholders prioritize interoperability and open architectures, companies that invest in standards-based integration and developer ecosystems are better positioned to capture long-term value and expand into adjacent digital health domains.

A practical, multi-pronged strategic playbook that aligns product modularity, software and services, supply chain resilience, and regional go-to-market execution for sustained advantage

Industry leaders must adopt a pragmatic, multi-dimensional playbook to capitalize on opportunities while mitigating operational and policy risks. First, prioritize product modularity and design for localization to reduce exposure to tariff-driven cost volatility and enable faster regional assembly or configuration. Second, deepen investments in software and services that augment hardware value-particularly AI-enabled analytics, cloud or hybrid data management and clinician-focused training-to create recurring revenue streams and improve retention. Third, strengthen supply chain transparency through multi-sourcing, strategic inventory buffers for critical components, and contractual protections that address trade contingencies.

In parallel, align go-to-market approaches with regional nuances by tailoring pricing and distribution models to local procurement practices and end-user capabilities, while ensuring robust aftermarket arrangements that guarantee uptime and parts availability. Foster strategic partnerships with systems integrators, clinical networks and technology vendors to enhance interoperability and accelerate clinical validation. Finally, embed data governance, cybersecurity and regulatory readiness into product development and service delivery to meet institutional expectations and expedite procurement decisions. Taken together, these actions enable organizations to sustain competitiveness, support clinical adoption, and adapt to a rapidly evolving policy and technology environment.

An evidence-driven methodology combining expert interviews, systematic literature analysis, scenario assessment, and cross-validation to ensure rigorous and actionable insights

The research approach integrated primary and secondary methods to generate a robust evidence base and validate thematic findings through stakeholder triangulation. Primary research comprised structured interviews and expert consultations with clinical leaders, procurement specialists, imaging technologists, and senior executives from manufacturers and distributors, enabling direct insight into operational challenges, adoption drivers, and service expectations. Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, patent filings, company disclosures and technical whitepapers to map technology trends and historical developments.

Data synthesis employed qualitative coding to identify recurring themes and quantitative aggregation where appropriate to describe adoption patterns and service models, while scenario-based analysis explored the implications of policy shifts, such as trade measures, on supply chains and procurement behavior. To ensure rigor, findings were cross-validated with independent expert panels and reconciled against known regulatory and clinical standards. Limitations included variability in publicly available operational metrics across regions and the evolving nature of AI and software regulations, which necessitated careful contextualization and conservative interpretation of near-term implications. Ethical considerations guided interview protocols and data handling to protect confidentiality and ensure objective analysis.

A concise synthesis that connects technology progress, service-driven differentiation, and supply chain resilience as the core determinants of sustained adoption and value delivery

In synthesis, the medical imaging sector is undergoing a sustained period of transformation driven by converging advances in hardware, analytics, and service delivery models alongside shifting policy and procurement dynamics. Modality-specific innovation continues to expand diagnostic and therapeutic capabilities, but the decisive differentiators increasingly reside in software integration, aftermarket services and supply chain adaptability. Trade policy developments have heightened the importance of localization, modular design and diversified sourcing, prompting stakeholders to reassess procurement frameworks and prioritize total lifecycle value.

Going forward, successful organizations will balance investment in core imaging performance with strategic software capabilities, clinician-centered training programs, and resilient distribution and service networks that accommodate regional nuances. By aligning product design, commercial models and operational processes with the realities of regulatory environments, deployment preferences and end-user needs, vendors and providers can better support clinical outcomes while preserving financial and operational stability. Ultimately, a deliberate focus on interoperability, service excellence and risk-managed supply chains will underpin sustained adoption and innovation across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam CT
    • 8.1.2. PET-CT
    • 8.1.3. Spectral CT
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Optical Imaging
  • 8.5. Ultrasound
  • 8.6. X Ray

9. Medical Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
    • 9.2.1. Installation & Integration
    • 9.2.2. Maintenance & Support
    • 9.2.3. Training & Education
  • 9.3. Software

10. Medical Imaging Market, by Application

  • 10.1. Cardiology
  • 10.2. Gastroenterology
  • 10.3. Neurology
  • 10.4. Obstetrics & Gynecology
  • 10.5. Oncology
  • 10.6. Orthopedics
  • 10.7. Urology

11. Medical Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Medical Imaging Market, by Anatomy

  • 12.1. Abdominal
  • 12.2. Brain
  • 12.3. Breast
  • 12.4. Cardiovascular
  • 12.5. Musculoskeletal
  • 12.6. Pediatrics
  • 12.7. Spine

13. Medical Imaging Market, by Deployment Mode

  • 13.1. Cloud
  • 13.2. On Premise

14. Medical Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Imaging Market

18. China Medical Imaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agfa-Gevaert Group
  • 19.6. Analogic Corporation
  • 19.7. Bracco Imaging S.p.A.
  • 19.8. Canon Medical Systems Corporation
  • 19.9. Carestream Health, Inc.
  • 19.10. Carl Zeiss Meditec AG
  • 19.11. Esaote S.p.A.
  • 19.12. Fujifilm Holdings Corporation
  • 19.13. GE HealthCare Technologies Inc.
  • 19.14. Hitachi, Ltd.
  • 19.15. Hologic, Inc.
  • 19.16. Konica Minolta, Inc.
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Mindray Medical International Limited
  • 19.19. Planmeca Oy
  • 19.20. RadNet, Inc.
  • 19.21. Samsung Medison Co., Ltd.
  • 19.22. Shimadzu Corporation
  • 19.23. Siemens Healthineers AG
  • 19.24. Varex Imaging Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 218. GCC MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. GCC MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GCC MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 223. GCC MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. G7 MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 249. G7 MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 250. G7 MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. G7 MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. G7 MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. NATO MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)